LAKE OSWEGO, Ore., March 7, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will present a corporate update at the 24th Annual ROTH Conference. The presentation will take place on Tuesday, March 13, 2012 at 2:30 p.m. PDT at the Ritz-Carlton, Laguna Nigel, CA.
